Iwakami Takayuki, Yamada So, Ogasawara Yoshifumi, Son Jaehyun
Department of Neurosurgery, Yuuai Medical Center, Shinmatsudo Central General Hospital.
Department of Neurosurgery, Shinmatsudo Central General Hospital.
Rinsho Shinkeigaku. 2022 Mar 29;62(3):184-189. doi: 10.5692/clinicalneurol.cn-001656. Epub 2022 Mar 25.
A 31-year-old man visited our hospital due to experiencing severe headaches, vomiting, and hypesthesia in the left side of his body. He had no past illnesses and had had no severe headaches before. The symptoms started the day after receiving the coronavirus disease 2019 (COVID-19) vaccination with Tozinameran. An MRI revealed cerebral venous sinus thrombosis and high intensity (DWI & FLAIR) of the right thalamus. Anticoagulant therapy was initiated, and his symptoms improved gradually. The follow-up MRI showed recanalization in a large part of the occluded venous sinuses. Most of the coagulation tests were normal, except for slightly high value of D-dimer, and the polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was negative. Further cases are needed to judge if there is some sort of relationship between the vaccination and the cerebral venous sinus thrombosis.
一名31岁男性因出现严重头痛、呕吐及左侧身体感觉减退前来我院就诊。他既往无疾病史,之前也未曾有过严重头痛。这些症状在接种托珠单抗进行2019冠状病毒病(COVID - 19)疫苗接种后的第二天开始出现。磁共振成像(MRI)显示脑静脉窦血栓形成以及右侧丘脑高强度信号(弥散加权成像[DWI]及液体衰减反转恢复序列[FLAIR])。随即开始抗凝治疗,其症状逐渐改善。随访MRI显示大部分闭塞的静脉窦再通。除D - 二聚体值略高外,大多数凝血检查结果正常,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的聚合酶链反应(PCR)检测为阴性。需要更多病例来判断疫苗接种与脑静脉窦血栓形成之间是否存在某种关联。